Showing results (491-500 of 658) with videos related to
Sort By:
Pageof 66
The Lancet. Oncology|February 3, 2020
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative reportTerri S Armstrong, Linda Dirven, David Arons, et al.Journal of Experimental & Clinical Cancer Research : CR|April 7, 2022
Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by Isovalerylspiramycin IJing Cui, Jingcheng Zhou, Weiqing He, et al.Nature Communications|February 10, 2022
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy targetNourhan Abdelfattah, Parveen Kumar, Caiyi Wang, et al.Neuro-Oncology|January 8, 2023
Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survivalBenjamin M Ellingson, Patrick Y Wen, Susan M Chang, et al.JNCI Cancer Spectrum|March 28, 2025
Prevalence of symptomatic toxicities for novel therapies in adult oncology trials: a scoping reviewAmanda L King, Tamara Vasilj, Diane Cooper, et al.Neuro-Oncology|March 5, 2008
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignanciesMorris D Groves, Michael J Glantz, Marc C Chamberlain, et al.Neuro-Oncology|June 19, 2008
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor ConsortiumSusan M Chang, Kathleen R Lamborn, John G Kuhn, et al.Neuro-Oncology|April 29, 2017
Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patientsJavier M Figueroa, Johan Skog, Johnny Akers, et al.Neuro-Oncology|March 8, 2026
Oncolytic Adenoviral Infection of Chordoma Achieves Treatment Efficacy Associated with Immunologic Response and Tumor Microenvironmental AlterationXizi Wu, Daniel Ledbetter, Jen-Wei Tsai, et al.Medrxiv : the Preprint Server for Health Sciences|March 10, 2025
Recurrent ERBB2 alterations are associated with esophageal adenocarcinoma brain metastasesNora M Lawson, Lingqun Ye, Chae Yun Cho, et al.Pageof 66